The purpose of the present study was to assess factors associated with quality of life (QOL) and to determine whether anxiety and depression are predictive of QOL in patients with advanced gastrointestinal cancer at initial diagnosis and during the treatment process. Methods: One hundred and twenty patients with gastrointestinal cancer requiring palliative chemotherapy were enrolled. Results: At baseline, depression, performance status, and anxiety accounted for 55.0% (p<.001) of the variance in global health status score, depression accounted for 22.0% (p<.001) of the variance in functional scales score, and anxiety accounted for 19.0% (p<.001) of the variance in symptom scales score. At 3 months, depression, pain, and performance status accounted for 72.0% (p<.001) of the variance in global health status score, 76.0% (p<.001) of the variance in functional scales score, and 74.0% (p<.001) of the variance in symptom scales score. Conclusion: Anxiety and depression were significant predictive factors of QOL in patients with advanced gastrointestinal cancer. Depression and performance status were significant predictive factors of QOL at both baseline and 3 months, and anxiety and pain were significant predictive factors of QOL at baseline and 3 months, respectively.
INTRODUCTION
The worldwide incidence of gastrointestinal cancer is relatively high compared with other cancers.
1) Gastric cancers occur most frequently in males, and gastrointestinal cancers, including stomach, colon, rectum, liver, pancreas, and gallbladder cancer, are among the ten leading types of new cancer cases in both males and females in Korea. 2) Although the overall incidence of advanced or metastatic gastrointestinal cancer has been lowered through early screening, and patients with early gastrointestinal cancer can be cured by surgical resection, a large majority of patients experience a relapse after surgical resection or are initially diagnosed with locally advanced unresectable or metastatic disease. 2, 3) For patients with advanced gastrointestinal cancer requiring palliative therapy, the 5-year survival rate has been reported to be 1.7~19.0%. [2] [3] [4] Traditionally, the primary goal of cancer therapy has been to decrease tumor size and increase overall survival rate. However, indicators of the efficacy of cancer therapy have expanded to include not only survival rate, but also quality of life (QOL), and QOL is an independent prognostic factor for survival rate in cancer patients. 5, 6) QOL is an important outcome measure in all cancer patients, and is particularly critical in patients with metastatic cancer as their treatment is limited to palliative therapy and cure is no longer the goal. QOL is a multidimensional concept that includes physical, psychological, social and cognitive functioning, and the impact of illness and treatment on the patient's life. 7, 8) Psychological distress such as anxiety or depression is common in cancer patients, reduces QOL, and increases mortality rate. [9] [10] [11] Furthermore, psychological distress can change during the course of cancer treatment after initial diagnosis. 12, 13) Therefore, comprehensive and periodic patient assessment focused on psychological as well as physical aspects should be incorporated into the treatment process for cancer patients, particularly those with advanced or metastatic cancer. Although there are many studies on psychological distress and QOL in cancer patients, [14] [15] [16] [17] [18] there are few studies on the relation between psychological distress and QOL in patients with advanced or metastatic gastrointestinal cancer. 19, 20) The objective of this study was to assess the factors associated with QOL, pain, anxiety, and depression were evaluated at initial diagnosis of advanced gastrointestinal cancer (study enrollment) and during the palliative treatment process (3 months after study enrollment). The reason for setting 3 months as the point of the palliative treatment process is that most of the patients will have active anticancer treatment at the 3 months after initial diagnosis even considering the gastrointestinal cancer with poor prognosis such as liver, pancreas, and bile duct cancers.
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Statistical analysis
Data are summarized as frequencies and percentages for categorical variables, and mean and standard deviation (SD) for continuous variables. QOL, pain, anxiety, and depression were compared between baseline and 3 month time points using independent sample t-tests. 
RESULTS
Patient characteristics
Of the 129 patients screened between July 2012 and June 2014, 120
were included in the study. Nine patients were excluded because of cognitive impairment (n=2), refusal to participate (n= 4), or inability to fill in the questionnaires (n =3) (Fig. 1) . Of the 120 patients included in the study, 100 patients (83.3%) completed the anxiety, depression, and QOL evaluations at baseline and at 3 month time points, and 20 had incomplete data at the 3 month time point because they were lost to follow-up (n =11) or died before the 3 month assessment (n = 9) (Fig. 1) . The sociodemographic and clinical characteristics of the 120 patients included in the study are shown in Table 1 . There was no significant change in QOL (EORTC QLQ-C30 score), pain (NRS score), anxiety (HADS anxiety score), or depression (HADS depression score) between baseline and 3 months (Table 2 ).
Sociodemographic and clinical factors associated with QOL
QOL according to sociodemographic and clinical factors at baseline and 3 months are listed in Table 3 . At baseline, the EORTC QLQ-C30 global health status score was greater in employed patients than in unemployed patients, greater in patients with low ECOG PS scores than in patients with high ECOG PS scores. The EORTC QLQ-C30 symptom scales score was greater (indicating worse QOL) in patients aged< 50 years than in patients aged 50~59 years, 60~69 years, and>70 years, and greater in patients aged 50~59 years than in patients aged 60~69 years and>70 years.
At 3 months, the EORTC QLQ-C30 global health status score was greater in patients with low ECOG PS scores than in patients with high ECOG PS score. The EORTC QLQ-C30 functional scales score was greater in patients who had not completed high school than in patients who had completed high school, and greater in patients with low ECOG PS scores than in patients with with high ECOG PS score. The EORTC QLQ-C30 symptom scales score was greater (indicating worse QOL) in patients who had completed high school than in patients who had not completed high school, lower (indicating better QOL) in in patients with low ECOG PS score than in patients with high ECOG PS scores.
3. Correlations between QOL and pain, anxiety, and depression lations between continuous variables (pain, anxiety, and depression) and QOL were quantified using Pearson's correlation coefficients.
At both baseline and 3 months, factors affecting QOL were identified using a multiple regression analysis based on a stepwise method. Prior to the regression analysis, we performed an independent validation of the homoscedasticity and normality of errors. This was followed by the validation of multicolinearity.
p<.05 was considered statistically significant. All statistical analyses were performed using SPSS for Windows software, version 18.0 (SPSS Inc., Chicago, IL). (Table 4 ). The strength of the correlations between QOL and pain, anxiety, and depression were greater at 3 months than at baseline. At both time points, the strength of the correlation between QOL and depression was stronger than that between QOL and anxiety, with the exception of the symptoms dimension of QOL (EORTC QLQ-C30 symptom scales score) at baseline. With the progression of the treatment, patients may become more aware of the significance of the cancer diagnosis, and this is likely followed by an increased awareness of the effects of the disease on all aspects of life.
This may lead to patients becoming more depressed. In patients with advanced cancer requiring palliative therapy, there is a gradual increase in uncomfortable somatic symptoms, and this is accompanied by difficulties associated with treatment procedures such as chemotherapy. This may also contribute to an increase in depressive symptoms.
Pain is one of the most common symptoms in cancer patients, and significantly affects the functional status and QOL of cancer patients. 28, 29) In a previous study of patients with gastrointestinal cancer, the presence of cancer pain was associated with a higher prevalence of depression and a lower QOL (global health status), role and emotional functioning. 18) The incidence of cancer pain in the present study was much lower (38% at baseline and 54.2% at 3 months) than in previous p<.001) of the variance in EORTC QLQ-C30 symptom scales score.
Depression and ECOG PS were significant predictors of QOL at baseline and 3 months, anxiety was a significant predictor of QOL at baseline, and pain was a significant predictor of QOL at 3 months.
DISCUSSION
No previous study has reported relationship between psychological distress and QOL in Korean patients with advanced gastrointestinal cancer, despite the incidence of gastrointestinal cancer has a higher inci- There is accumulating evidence of an association between psychological distress and QOL in cancer patients. [14] [15] [16] [17] [18] In Korea, the prevalence of anxiety or depression in cancer patients has been estimated as 28.8~56.5% when all stages and cancer types are considered. 25, 26) However, there are few studies that have focused on anxiety and depression in patients with gastrointestinal cancer, or that have reported an association between psychological distress and QOL in patients with gastrointestinal cancer. 19, 20, 27) Alacacioglu et al 20) reported that anxiety and depression were strongly associated with poor QOL in Turkish colorectal cancer patients, and Tsunoda et al 27) reported that depression had a stronger impact than anxiety on the global QOL of colorectal cancer patients. In the present study, participants reported a moderate level of QOL. This is consistent with a previous study of patients with advanced colorectal cancer, 20) but symptom QOL in our study was much lower (indicating better QOL) than that reported in a study of patients with metastatic gastrointestincal cancer, 23) because esophageal cancer was the studies conducted on patients with metastatic cancer (64~90%). 28) Many previous studies have included inpatients with metastatic cancer or patients with progressive cancer after the initial diagnosis of metastatic cancer. 28) By contrast, the current study focused on patients who were initially diagnosed with advanced gastrointestinal cancer at the outpatient clinic. In the current study, cancer pain was significant predictive factor of all dimensions of QOL after 3 months of treatment, i.e., at the time when there is a gradual increase in pain associated with the adverse effects of cancer therapy, such as chemotherapy or progression of the cancer itself.
The present study has several limitations. 
